JBIOJade Biosciences, Inc.

$14.42+94% 1Y

The financials

Jade Biosciences, Inc. by the numbers

The next results filing is expected around Nov 13, 2026, the same week as a year ago.

Jade Biosciences, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$59M−$28Mn/a
Net income−$56M−$32Mn/a
Diluted EPS−$0.76−$0.86n/a
On our screens:Most shorted stocks